Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
3.690
+0.140 (3.94%)
Nov 4, 2024, 4:00 PM EST - Market closed

Sutro Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
302261464689988254
Upgrade
Market Cap Growth
-14.69%-43.69%-32.55%-30.31%288.95%23.24%
Upgrade
Enterprise Value
-108-55193453731115
Upgrade
Last Close Price
3.554.298.0814.8821.7111.00
Upgrade
PE Ratio
--2.42-3.44-6.50-21.93-4.53
Upgrade
PS Ratio
1.381.706.8511.1323.125.94
Upgrade
PB Ratio
1.911.752.142.732.982.60
Upgrade
P/FCF Ratio
-3.08-2.26-107.77-7.10-13.18-3.71
Upgrade
P/OCF Ratio
-3.21-2.34130.85-8.43-14.57-3.91
Upgrade
EV/Sales Ratio
-0.27-0.362.857.3217.112.69
Upgrade
EV/EBITDA Ratio
0.460.67-1.57-4.84-10.95-2.26
Upgrade
EV/EBIT Ratio
0.430.62-1.50-4.60-10.29-2.07
Upgrade
EV/FCF Ratio
0.590.48-44.81-4.67-9.76-1.68
Upgrade
Debt / Equity Ratio
0.170.220.230.230.070.10
Upgrade
Debt / FCF Ratio
-0.34-0.29-11.70-0.59-0.33-0.14
Upgrade
Asset Turnover
0.360.350.180.170.160.23
Upgrade
Quick Ratio
3.334.395.135.0412.633.77
Upgrade
Current Ratio
3.414.505.315.2412.783.90
Upgrade
Return on Equity (ROE)
-81.10%-58.25%-50.77%-36.11%-14.95%-48.62%
Upgrade
Return on Assets (ROA)
-13.91%-12.71%-21.54%-16.74%-16.14%-18.32%
Upgrade
Return on Capital (ROIC)
-35.28%-24.76%-27.91%-18.48%-19.13%-27.38%
Upgrade
Earnings Yield
-42.77%-40.84%-25.67%-15.33%-3.25%-21.95%
Upgrade
FCF Yield
-26.70%-44.33%-0.93%-14.09%-7.58%-26.97%
Upgrade
Buyback Yield / Dilution
-15.62%-18.57%-10.02%-41.58%-41.88%-298.66%
Upgrade
Total Shareholder Return
-15.62%-18.57%-10.02%-41.58%-41.88%-298.66%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.